Our press releases
We upload all our regulatory and non-regulatory press releases in chronological order here. Each press release states the relevant contact. You can filter between the regulatory and non-regulatory categories below.
Press releases
2024-10-24
Regulatory information
Interim Report 1 January – 30 September 2024: Market still challenging in the third quarter
Third quarter 2024 • Net sales SEK 460.9 million (524.5) • EBITA SEK 11.2 million (40.6), adjusted for non-recurring items SEK 19.0 million (40.6) • EBITA margin 2.4 percent (7.7), adjusted for non-recurring items 4.1 percent (7.7) • EBIT SEK 9.0 million (36.7), adjusted for non-recurring...
2024-07-12
Regulatory information
Interim Report 1 January – 30 June 2024: A still-challenging market burdened the second quarter
Second quarter 2024 Net sales SEK 439.6 million (478.9) EBITA SEK 21.2 million (38.0), adjusted for non-recurring items SEK 24.1 million (38.0) EBITA margin 4.8 percent (7.9), adjusted for non-recurring items 5.5 percent (7.9) EBIT SEK 18.9 million (34.4), adjusted for non-recurring items SEK 21.8...
2024-05-14
Regulatory information
Dedicare Implements Management Changes in Sweden and Initiates Cost-Saving Program
Dedicare is undergoing a management change in Sweden, where Bård Kristiansen, CEO of Dedicare Norway since 2017, will take over as interim CEO for Dedicare Sweden. Bård will continue as CEO for Dedicare Norway, while Lene Langås, operational manager within nurse staffing since 2013, will be appointed...
2024-04-25
Regulatory information
Dedicare updates profitability target for 2024
Dedicare has had a financial profitability target of its EBIT margin exceeding 7.0 percent. Its Board of Directors has decided to change its profitability target to an EBITA margin of 7.0 percent over time. Dedicare’s strategy is acquisition-led growth. The reason for this change is to enable...
Regulatory information
Dedicare adjusts segment reporting
Dedicare is changing the allocation of costs in its segment structure from its First-quarter Interim Report 2024 onwards. In the previous segment reporting, shareholder-related expenses were allocated between all segments. Effective the first quarter 2024, all these expenses will be reported in the Group-wide...
Regulatory information
Interim Report 1 January – 31 March 2024: A challenging start to 2024
First quarter 2024 • Net sales SEK 430.2 million (503.2) • EBITA SEK 17.4 million (41.6) • EBITA margin 4.0 percent (8.3) • EBIT SEK 15.1 million (38.0) • EBIT margin 3.5 percent (7.6) • Profit after financial items SEK 13.5 million (31.3) • Profit for the period SEK 10.5...
12